Fischhaber, N.; Schmiedeberg, M.; Kübel, S.; Harrer, E.G.; Harrer, T.; Nganou-Makamdop, K.
Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy. Vaccines 2023, 11, 211.
https://doi.org/10.3390/vaccines11020211
AMA Style
Fischhaber N, Schmiedeberg M, Kübel S, Harrer EG, Harrer T, Nganou-Makamdop K.
Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy. Vaccines. 2023; 11(2):211.
https://doi.org/10.3390/vaccines11020211
Chicago/Turabian Style
Fischhaber, Natalie, Moritz Schmiedeberg, Sabrina Kübel, Ellen G. Harrer, Thomas Harrer, and Krystelle Nganou-Makamdop.
2023. "Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy" Vaccines 11, no. 2: 211.
https://doi.org/10.3390/vaccines11020211
APA Style
Fischhaber, N., Schmiedeberg, M., Kübel, S., Harrer, E. G., Harrer, T., & Nganou-Makamdop, K.
(2023). Ex Vivo Blockade of the PD-1 Pathway Improves Recall IFNγ Responses of HIV-Infected Persons on Antiretroviral Therapy. Vaccines, 11(2), 211.
https://doi.org/10.3390/vaccines11020211